At least 12 of my colleagues boarded planes to the American Society of Clinical Oncology conference in Chicago last week to hear Charles Swanton of the Francis Crick Institute in London share results ...
Methods We conducted a cost-effectiveness analysis in the Yorkshire Lung Screening Trial (YLST) population comparing three ...
A new study suggests that a blood-based protein signature may help identify people at risk of lung cancer more accurately ...
Scientists have identified proteins that could signal increased lung cancer risk, as well as a drug that could reduce the odds of a tumor developing. By Nina Agrawal Scientists have made a discovery ...
For every 10 scans containing an abnormality, a radiologist is likely to miss three of them. This is a problem because ...
A model based on proteins vs. a questionnaire had higher discrimination in predicting lung cancer risk in individuals with a smoking history, according to data presented at the American Thoracic ...
Pigeons are inspiring a new wave of AI for medical diagnostics. Researchers are studying how these birds process visual ...
Ivonescimab's landmark overall survival win against PD-1 in their chemotherapy combinations in first-line lung cancer drew both hope and criticism at ASCO 2026. (Angus Liu/Fierce Pharma) It’s the ...
When confronted with cancer, Connor Christou fed everything tied tied to his regime — blood results, scan data, wearable ...
For decades, cancer screening has relied on individual tests such as mammograms, colonoscopies, Pap smears, low-dose CT scans, and PSA testing. However, advances in genomic technology have led to the ...